Pathological Pattern of Intrahepatic HBV in HCC is Phenocopied by PDX-Derived Mice: a Novel Model for Antiviral Treatment
BACKGROUND: Hepatitis B virus (HBV) is one of the most prominent risk factors for hepatocellular carcinoma (HCC) development and virus-mediated cases represents more than 80% of HCC in East Asia, where it is endemic. Currently, the HBV status of pathological HCC is not fully clarified, especially by...
Main Authors: | Jiao Liu, Siyuan Chen, Zhe Zou, Dehong Tan, Xiangde Liu, Xing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523319301159 |
Similar Items
-
Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
by: Vicki Wing-Ki Hui, et al.
Published: (2020-12-01) -
Occult HBV infection and HCC
by: Isabelle Chemin
Published: (2007-02-01) -
HBV-Induced Immune Imbalance in the Development of HCC
by: Yongyan Chen, et al.
Published: (2019-08-01) -
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Chen, L., et al.
Published: (2022) -
Hsa-miR122 regulates intrahepatic metastasis of HCC
by: Wei-Chih Tsai, et al.
Published: (2008)